The 2011 BIO International Convention brings together leaders, innovators, and companies in the largest global event for the biotechnology industry. This is when and where you can see and hear insights, inspiration and what’s next in biotech.
But what if you aren’t there or can’t be in two places at once while there?
Keep up with what’s happening at Convention on BIOTechNOW, our new website, and also via the bloggers who are covering events day-by-day and minute-by-minute. These bloggers, who are at the top of the biotechnology beat, will cover Convention happenings on BIOTechNow and their own blogs.
Catch their highlights, analysis, and discussions, as well as join in the conversation with the bloggers and your peers. Do more than just read, too: ask questions, answer questions, add opinions, learn about reactions in the sessions—it’s a conversation so join in. In fact, we plan to continue this coverage and conversation all year long so you can keep up with industry news. BIO and these bloggers, who have an open invitation on BIOTechNOW will keep you abreast of BIO’s work on the issues, insights into major biotech news, and a connection to what is happening within the industry. Make sure to bookmark their blogs, add them to your RSS feeds, follow their Tweets, and keep tabs on hashtag #BIO2011.
- John Carroll at Fierce Biotech – follow John at @JohnCFierce
About John: John is a biotech analyst with 32 years of prize-winning experience in journalism. Appointed editor of FierceBiotech in 2003, he has covered genomics, biotechnology, healthcare and more.
- Angie Drakulich and Amy Ritter at PharmTech Talk
About Angie: Angie joined Pharmaceutical Technology in 2007, where she covers global health, biopharmaceutical, academic, government, and donor communities in support of bio/pharmaceutical research and development, among other pharma topics.
- Yali Friedman at Biotech Blog – follow Yali at @thinkbiotech
About Yali: Yali Friedman, Ph.D., is founder of thinkBiotech and chief editor of the Journal of Commercial Biotechnology. His book, Building Biotechnology, is used as a course text in dozens of biotechnology programs.
- Brady Huggett at Trade Secrets – follow Brady at @naturebiotech
About Brady: Brady is the Business Editor for Nature Biotechnology. Since 1998, Nature Biotechnology’s Bioentrepreneur has been capturing key insights and advice for those directly involved in shaping the innovative biotech sector.
- Kevin Noonan at Patent Docs – follow Kevin at @patentdocs
About Kevin: Kevin combines his JD and PhD in molecular biology to represent pharmaceutical and biotechnology companies both large and small in all aspects of patent prosecution, interference, litigation, and client counseling on validity, infringement, and patenting strategy matters.
- Steven Overly at Capitol Business – follow Steven at @StevenOverly
About Steven: Steven Overly covers local business, specifically technology, entrepreneurship and venture capital, for The Washington Post and its weekly Capital Business section.
- Gene Quinn at IP Watchdog – follow Gene at @ipwatchdog
About Gene: Gene is a US Patent Attorney who runs one of the top intellectual property blogs on the Internet.
- Mike Spear at Genome Alberta – follow Mike at @mikesgene
About Mike: Mike is the Director of Corporate Communications at Genome Alberta, where he covers Agriculture/Forestry/Environment/Byproducts, Biomedical/Health, Life Sciences Technologies, and last but not least Genomics Ethical, Economic, Environmental and Legal Studies (GE³LS).
- Betsy Raymond Stevenson at Snapshot – follow Betsy at @Betsy_RSHC
About Betsy: Betsy knows that most of us are involved in the healthcare industry because we want to contribute in a meaningful way to improve public health. She founded RaymondStevenson Healthcare Communications in 2007, to strengthen relationships between the pharmaceutical and biotechnology industries. Betsy speaks and writes frequently on healthcare communications, industry reputation, and the changing media landscape.
- Don Zuhn at Patent Docs – follow Don at @patentdocs
About Don: Don has more than a decade of experience in all aspects of patent prosecution, litigation, counseling, and licensing. He represents a variety of clients, including biotechnology and pharmaceutical companies both large and small, and universities.